Identification and counseling for obesity among children on psychotropic medications in ambulatory settings

Abstract

Objective: To examine identification and counseling for obesity at pediatric office visits associated with psychotropic medications. Design and Methods: Analysis of ambulatory care visits by children 2-17 years in the National Ambulatory Medical Care Surveys and outpatient component of the National Hospital Ambulatory Medical Care Surveys from 2005 to 2008. Physician identification of obesity was determined using ICD-9 CM diagnostic codes. Results: In 2005-2008, there were 38,539 pediatric ambulatory care visits weighted to represent 600 million pediatric visits nationally. Psychotropic medications were associated with 5.2% of visits. The prevalence of overweight/obesity (BMI 85th%tile) was 15.9% for visits without psychotropic medication, 19.4% and 16.8% for visits associated with nonobesogenic and obesogenic psychotropic medications, respectively. Controlling for age, gender, and BMI, obesity was more likely to be identified at visits associated with psychotropic medications (OR 5.2, 95% CI 3-8.8), among females (OR 1.6, 95% CI 1.1-2.3) and non-Hispanics (OR 1.5, 95% CI 1.0-2.4). At visits with psychotropic medications, dietary counseling was provided at 11.4%, while blood pressure and cholesterol screening were obtained at 6.9% and 6.8% of these visits, respectively. Conclusions: Our results indicate suboptimal identification and counseling for obesity children who are prescribed psychotropic medications, despite their increased risk for weight gain.

Family‐Style Dining on a Child and Adolescent Psychiatry Unit: A Quality Improvement Project to Reduce Weight Changes in Patients

“…Within the past 10 years, there has been an increase in the number of children and adolescents seeking treatment for and being diagnosed with psychiatric disorders. Concurrently, the use of neuroleptics to treat these children has increased (Eneli, Wang, & Kelleher, ). Physicians are now treating children with neuroleptics not only for psychosis but for behavioral problems such as oppositional defiant disorder, irritability linked to autism, and bipolar affective disorder (Findling, Steiner, & Weller, ).…”

Clinical approaches to minimize iatrogenic weight gain in children and adolescents

“…T A B L E 1 Medications and weight gain Adapted from Eneli et al40 and β 2 agonists 19,20. Children with obesity have an equivalent or improved response to montelukast compared to children with normal weight, making it a good adjunctive therapy for asthma 20.…”